<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-05-02 12:07:18Research Muscular dystrophy Pharmaceutical industry Motor neurone disease Rare diseases TREAT-NMD Duchenne muscular dystrophy Clinical trial Amyotrophic lateral sclerosis Health Medicine Clinical research |
Add to Reading List |
_A01: Financing Network Durability | DOCX DocumentDocID: 1wwhs - View Document |
| DOCX DocumentDocID: 1wv76 - View Document |
| PDF DocumentDocID: 1w4hN - View Document |
| -Application for Renewal of RDMM Catalyst Grants This application is to be used by the Network’s Scientific Advisory Committee (SAC) to determine as to whether to provide an additional year of funding ($DocID: 1vceh - View Document |
| MULTISYSTEMIC RARE DISEASESDocID: 1v3AN - View Document |